MedVi Black Friday Semaglutide Deals – Big Savings on GLP-1 Plans
The MedVi Black Friday promotion presents time-limited reductions on clinician-supervised GLP-1 medication access for adults seeking medically supervised weight management. This announcement outlines the structure of the offer, the medications available via telehealth, and the procedural steps for remote evaluation and prescription. The presentation is strictly informational; individual eligibility, clinical suitability, and outcomes require consultation with a licensed clinician.
What Is MedVi?
MedVi is a telehealth provider that facilitates remote clinical assessment and prescription of GLP-1 therapies when clinically appropriate. The organization operates a nationwide telehealth platform to enable online medication access and follow-up care, connecting patients with licensed clinicians to evaluate indications, contraindications, and safer-use considerations. MedVi’s services emphasize remote intake, clinician review, and pharmacy fulfillment under applicable state and federal regulations.
Black Friday Deal Overview
During the Black Friday period, MedVi is offering discounted prices on select GLP-1 regimens to broaden access to telehealth-managed options. The promotion reduces the monthly cost of injectable Semaglutide and Tirzepatide plans and includes an introductory reduction applied to the first month for eligible new patients. The advertised Black Friday prices are offered as promotional pricing for the duration of the campaign and represent discounted online medication access rather than a clinical endorsement of suitability.
Specifically, Semaglutide is available at a Black Friday price of $179 per month and Tirzepatide at $279 per month. Additionally, a promotional credit of $120 off the first month may apply for new patients who meet intake requirements and complete an initial consultation. Prospective patients should verify the total cost, shipping, and any associated clinical fees during checkout.
GLP-1 Medications Offered
- Semaglutide (injectable formulations commonly prescribed for clinically indicated weight management; requires clinician approval)
- Tirzepatide (injectable GLP-1/GIP agent available under clinician supervision)
- Oral GLP-1 options: where clinically appropriate and available, oral semaglutide or other approved oral formulations may be considered subject to clinician determination
- Adjunctive counseling and prescription management services delivered via weight-loss telehealth
How MedVi Works
MedVi’s telehealth workflow typically includes a structured online intake, review of medical history and current medications, and a virtual consultation with a licensed clinician. If the clinician determines a GLP-1 medication is appropriate, a prescription is issued and fulfilled through a partnered pharmacy. Medication is shipped to the patient’s address pursuant to state prescribing rules. Follow-up and monitoring are conducted via telehealth visits and messaging to review tolerability, adverse events, and ongoing appropriateness.
All patients must provide accurate medical history and disclose concurrent conditions and medications. Clinicians will not prescribe GLP-1 agents to individuals for whom the therapy is contraindicated or unsafe. Patients should seek immediate medical attention for any concerning reactions and maintain regular communications with their prescribing clinician during therapy.
Pricing & Savings Breakdown
| Medication | Typical Retail Price (approx.) | MedVi Black Friday Price | First-Month Promo |
|---|---|---|---|
| Semaglutide | Approximately $250–$350 / month | $179 / month | $120 off first month (where applicable) |
| Tirzepatide | Approximately $350–$450 / month | $279 / month | $120 off first month (where applicable) |
Key Advantages
- Nationwide weight-loss telehealth access that reduces the need for in-person visits in many jurisdictions.
- Transparent promotional pricing for the Black Friday period, enabling prospective patients to evaluate cost.
- Clinician-led assessments that align prescriptions with medical history and safety considerations.
- Pharmacy fulfillment and home delivery that streamline online medication access.
- Structured follow-up to monitor tolerability and address questions remotely.
Potential Considerations
- Not all patients will be eligible for GLP-1 therapy; clinician assessment is required to determine safety and appropriateness.
- Common adverse events and individual tolerability vary; clinicians will advise on monitoring and dose adjustments.
- Promotional pricing applies only for the Black Friday period and may not reflect long-term subscription costs or membership fees.
- Insurance coverage for GLP-1 medications varies; patients should verify benefits prior to purchase.
Who This Black Friday Deal Is Best For
Individuals with reliable internet access seeking clinician-supervised GLP-1 evaluation via weight-loss telehealth, who meet clinical eligibility and are comfortable managing remote follow-up, may find MedVi’s Black Friday pricing of interest. Candidates should be prepared to provide comprehensive medical history and to adhere to clinician guidance. Those requiring in-person assessment or with complex medical comorbidities should consult local providers.
Final Verdict
MedVi’s Black Friday Semaglutide and Tirzepatide pricing offers a temporal reduction in cost for clinician-managed GLP-1 options through online medication access. For eligible patients interested in telehealth-managed therapy, the promotional pricing and first-month credit may present meaningful Black Friday savings; however, clinical suitability and safety remain the primary determinants of whether such therapy is appropriate. Prospective patients may also review additional Black Friday GLP-1 offers via independent listings such as the Explore Treatments resource for comparative offers and broader market context: Explore GLP1 Black Friday Deals. For further aggregated promotions, see other curated listings like GLP1 Black Friday Deals 2025.
This article contains general telehealth information which is as is and may not be accurate and is not a substitute for professional medical advice. All GLP-1 medications require a licensed clinician’s approval.